JP2018520201A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520201A5
JP2018520201A5 JP2018503142A JP2018503142A JP2018520201A5 JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5 JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
amino
triazin
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018503142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/043252 external-priority patent/WO2017015425A1/en
Publication of JP2018520201A publication Critical patent/JP2018520201A/ja
Publication of JP2018520201A5 publication Critical patent/JP2018520201A5/ja
Pending legal-status Critical Current

Links

JP2018503142A 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト Pending JP2018520201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562195854P 2015-07-23 2015-07-23
US62/195,854 2015-07-23
PCT/US2016/043252 WO2017015425A1 (en) 2015-07-23 2016-07-21 Tgf beta receptor antagonists

Publications (2)

Publication Number Publication Date
JP2018520201A JP2018520201A (ja) 2018-07-26
JP2018520201A5 true JP2018520201A5 (US06653308-20031125-C00057.png) 2019-08-15

Family

ID=56609944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503142A Pending JP2018520201A (ja) 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト

Country Status (6)

Country Link
US (1) US10336761B2 (US06653308-20031125-C00057.png)
EP (1) EP3325484A1 (US06653308-20031125-C00057.png)
JP (1) JP2018520201A (US06653308-20031125-C00057.png)
KR (1) KR20180032611A (US06653308-20031125-C00057.png)
CN (1) CN108026105B (US06653308-20031125-C00057.png)
WO (1) WO2017015425A1 (US06653308-20031125-C00057.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3008171A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
EP4331679A3 (en) 2017-06-21 2024-04-03 Shy Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US10653682B2 (en) * 2017-10-26 2020-05-19 Southern Research Institute Oxadiazoles and thiadiazoles as TGF-β inhibitors
KR20210110316A (ko) 2018-12-27 2021-09-07 넥시스 테라퓨틱스 인코포레이티드 암의 치료를 위한 tgf-베타 r1(alk5) 억제제로서의(피리딘-2-일)아민 유도체
CN111825675B (zh) * 2019-04-15 2023-08-01 武汉朗来科技发展有限公司 Rock抑制剂及其制备方法和用途
CN112694477B (zh) * 2019-10-22 2024-02-06 四川科伦博泰生物医药股份有限公司 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途
WO2021147699A1 (zh) * 2020-01-21 2021-07-29 四川科伦博泰生物医药股份有限公司 吡啶并杂环类化合物、其制备方法及用途
CN113620956B (zh) * 2020-05-06 2023-06-13 赛诺哈勃药业(成都)有限公司 转化生长因子受体拮抗剂、其制备方法和应用
WO2023196975A1 (en) * 2022-04-08 2023-10-12 Shy Therapeutics, Llc Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
WO2024015497A1 (en) * 2022-07-14 2024-01-18 Biogen Ma Inc. Tyrosine kinase 2 inhibitors and uses thereof
WO2024155842A1 (en) * 2023-01-19 2024-07-25 Skyhawk Therapeutics, Inc. Compositions useful for modulating splicing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065392A1 (en) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
JP2006521398A (ja) * 2003-03-28 2006-09-21 サイオス・インコーポレーテツド TGFβの二−環式ピリミジン阻害剤

Similar Documents

Publication Publication Date Title
JP2018520201A5 (US06653308-20031125-C00057.png)
US8871753B2 (en) Macrocyclic compounds and their use as kinase inhibitors
US9221809B2 (en) Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
KR101949624B1 (ko) Tank-결합 키나제 억제제 화합물로서 유용한 아미노트리아진 유도체
CA2814419C (en) Cxcr4 receptor antagonists
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
JP2013544256A5 (US06653308-20031125-C00057.png)
JP2011518836A5 (US06653308-20031125-C00057.png)
US9382241B2 (en) Aminoquinazoline and pyridopyrimidine derivatives
RU2425826C2 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb
RU2013124101A (ru) Гетероциклические амины и их применения
JP2021502356A5 (US06653308-20031125-C00057.png)
JP2019530667A (ja) ピリジル置換のインドール化合物
KR20210040368A (ko) 사이클린 의존성 키나제의 억제제
RU2010137300A (ru) Модуляторы бета-амилоида
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
SI3083586T1 (en) The new carboxamides, the process of their manufacture, the pharmaceutical preparations they contain and their use for the manufacture of medicinal products
RU2009121564A (ru) Азаадамантановые производные и способы применения
JP2016523911A5 (US06653308-20031125-C00057.png)
JP2015528022A5 (US06653308-20031125-C00057.png)
ES2557478T3 (es) Compuestos de pirazol y triazol como inhibidores de KSP
RU2009147733A (ru) Пиридилпиперидновые антагонисты рецептора орексинов
JP2008503501A5 (US06653308-20031125-C00057.png)
JP2018507235A5 (US06653308-20031125-C00057.png)
TW201604190A (zh) 吲哚啉-2-酮或吡咯并-吡啶-2-酮之衍生物